Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: IF ...
PTSC is able to get some solid settlements before any substantive legal decisions on infringement, I think PTSC should not announce them and use all the money at these levels to repurchase shares and hopefully get the float down to 300m shares. $20m between 10 and 20 cents over 2 to 3 months could get the float down while raising the price. IMO, PTSC management should keep any positive results quiet and use any funds to attempt to decrease the floatby 25% and then announce settlements and issue dividends. All of the above theoretically raises the SP with any positive developments and I'm sure it is easier said than done.
Share
New Message
Please login to post a reply